Data supplements
Online Appendices
- Appendix 1: Detailed Markov model of chronic hepatitis C virus infection and progression
- Appendix 10: Results of threshold analysis on the cost of interferon-free antiviral therapy
- Appendix 2: Detailed methodology section
- Appendix 3: Validation Results: Probability of cirrhosis and liver-death
- Appendix 4: Cost-Effectiveness Results for different age ranges
- Appendix 5: Cost-effectiveness results for treatment pattern changed for IFN-Free DAAs
- Appendix 6: Cost-effectiveness results for restricted treatment (F2 - F4)
- Appendix 7: Result of sensitivity analyses: tornado diagrams: "screen and treat" vs. "no screening"
- Appendix 8: Cost-Effectiveness Results for different prevalence assumptions
- Appendix 9: Result of sensitivity analyses: acceptability curve: "screen and treat" vs. "no screening" for 25 - 64 years old individuals. WTP = willingness to pay.